个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共5条记录   CEREBROLYSIN IN ALZHEIMER'S DISEASE [作者：Alvarez, XA; Fuentes, P,期刊：Drugs of today, 页码：487-513 , 文章类型： Article，,卷期：2011年47-7] Cerebrolysin is a neuropeptide preparation mimicking the action of endogenous neurotrophic factors. Positive effects of Cerebrolysin on beta-amyloid- and tau-related pathologies, neuroinflammation, neurotrophic factors, ... VELAGLUCERASE ALFA: A NEW OPTION FOR GAUCHER DISEASE TREATMENT [作者：Zimran, A,期刊：Drugs of today, 页码：515-529 , 文章类型： Article，,卷期：2011年47-7] Type 7 Gaucher disease (CD) results from inherited beta-glucocerebrosidase gene mutations, leading to anemia, thrombocytopenia, splenomegaly, hepatomegaly and skeletal disease. Velaglucerase alfa is a beta-glucocerebrosi... VILAZODONE: A NEW TREATMENT OPTION FOR MAJOR DEPRESSIVE DISORDER [作者：Owen, RT,期刊：Drugs of today, 页码：531-537 , 文章类型： Article，,卷期：2011年47-7] Vilazodone hydrochloride belongs to a new class of antidepressants-the indolalkylamines-and has dual activity as a selective serotonin reuptake inhibitor (SSRI) and as a partial agonist of the serotonin 5-HT(1A) receptor... AVAILABLE THERAPIES AND CURRENT MANAGEMENT OF FIBROMYALGIA: FOCUSING ON PHARMACOLOGICAL AGENTS [作者：Han, C; Lee, SJ; Lee, SY; Seo, HJ; Wang, SM; Park, MH; Patkar, AA; Koh, J; Masand, PS; Pae, CU,期刊：Drugs of today, 页码：539-557 , 文章类型： Review，,卷期：2011年47-7] Fibromyalgia (FM) is a chronic medical condition characterized by physical, psychiatric and psychological symptoms. Widespread pain, fatigue, sleep disturbances, heightened sensitivity, morning stiffness, decreased volit... RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATORS: "TIME MATTERS" [作者：Kunadian, V; Gibson, CM,期刊：Drugs of today, 页码：559-570 , 文章类型： Review，,卷期：2011年47-7] Although acute ST elevation myocardial infarction (STEM!) was described nearly a century ago, it remains a major health problem not only in the U.S. but also worldwide with more than three million people suffering STEMI ...